Your browser doesn't support javascript.
loading
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.
Arceci, Robert J; Sande, Jane; Lange, Beverly; Shannon, Kevin; Franklin, Janet; Hutchinson, Raymond; Vik, Terry A; Flowers, David; Aplenc, Richard; Berger, Mark S; Sherman, Matthew L; Smith, Franklin O; Bernstein, Irwin; Sievers, Eric L.
Affiliation
  • Arceci RJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 2M51, Bunting-Blaustein Cancer Research Bldg, 1650 Orleans St, Baltimore, MD 21231, USA. arcecro@jhmi.edu
Blood ; 106(4): 1183-8, 2005 Aug 15.
Article in En | MEDLINE | ID: mdl-15886328
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, Differentiation, Myelomonocytic / Leukemia, Myeloid / Antigens, CD / Salvage Therapy / Aminoglycosides / Antibodies, Monoclonal Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, Differentiation, Myelomonocytic / Leukemia, Myeloid / Antigens, CD / Salvage Therapy / Aminoglycosides / Antibodies, Monoclonal Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States